The Application segment partitions the Nutritional Fat Powder market according to end‑use environments, reflecting divergent functional requirements and regulatory constraints. Infant formula consumes roughly 30 % of total volume, as the powder supplies essential long‑chain polyunsaturated fatty acids required for neuro‑development while maintaining sterility standards. Medical nutrition accounts for about 25 %, providing energy‑dense formulations for patients with malabsorption, cachexia, or post‑surgical recovery, where precise fatty‑acid ratios are clinically mandated. Sports nutrition represents near 20 %, leveraging MCT‑rich powders to accelerate substrate oxidation and support endurance performance, a segment driven by premium pricing and targeted marketing. Functional foods occupy the remaining 25 %, integrating blended fat powders into bakery, dairy, and beverage products to enhance mouthfeel, shelf‑life, and health claims such as “heart‑healthy” or “low‑fat”. This Nutritional Fat Powder segmentation aligns market share with application‑specific value chains, enabling manufacturers to prioritize R&D investments, capacity planning, and compliance strategies in proportion to each segment’s revenue contribution.